Atencion Integral en Reumatologia (AIR)

Ciudad Autonoma Buenos Aires C1426AAL

0 studies enrolling now · 4 studies all time

What they study most

Lupus Erythematosus, Systemic, Rheumatoid Arthritis

Studies at this site

• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed